Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $52 at Baird
Tweet
Share
E-mailGet Alerts AMLX Hot Sheet
Price: $32.41 -4.51%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Baird analyst Joel Beatty raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $52.00 (from $28.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Downgrades Mapletree Logistics Trust (MLT:SP) (MAPGF) to Neutral
- TIME dotCom Berhad (TDC:MK) PT Raised to MYR7.50 at JPMorgan
- Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY7,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
